Vander Elst, Niels https://orcid.org/0000-0001-6289-7288
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (1.S.236.20N)
Karolinska Institute
Article History
Received: 6 January 2024
Accepted: 5 April 2024
First Online: 20 May 2024
Declarations
:
: This study did not require official or institutional ethical approval.
: Not applicable.
: The engineered endolysin NC5 in this work is the subject of an issued and pending patent submitted at the European Patent Office with application number EP 23164960.9 to which the author has inventorship.